000 01805nam  2200385zi 4500
0019.911521
003CaOODSP
00520221107182354
006m     o  d f      
007cr cn|||||||||
008220524t20222022qucd    o    f000 0 eng d
020 |a9780660436470
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH14-398/2022E-PDF
1001 |aGilbert, Marie-Line, |eauthor.
24510|aAt-a-glance : |bnewly reported psychoactive substances in Canada / |cMarie-Line Gilbert, Michèle Boileau-Falardeau, Cindy Leung Soo, Caroline Maurice-Gelinas, Mark Hrynkiw, Richard Laing, Stéphanie Lessard, Janike Pitre, Benoit Archambault.
24616|aNewly reported psychoactive substances in Canada 2020-2021
264 1|aLongueuil, QC : |bHealth Canada Drug Analysis Service, |c[2022]
264 4|c©2022
300 |a1 online resource (12 pages) : |bgraphs
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCover title.
500 |aIssued also in HTML format.
500 |aIssued also in French under title: Survol : substances psychoactives nouvellement déclarées au Canada.
520 |a"The aim of this report is to describe new psychoactive substances which emerged in Canada since 2020"--Aim, page 2.
650 0|aPsychotropic drugs|zCanada.
650 0|aOpioids.
7101 |aCanada. |bHealth Canada. |bDrug Analysis Service, |eissuing body.
77508|tSurvol : |w(CaOODSP)9.911520
85640|qPDF|s1.19 MB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H14-398-2022-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/publications/healthy-living/psychoactive-substances-canada-2020-2021.html